IL13RA1 - N-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-IL13RA1 - N-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IL13RA1 - N-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | cow, guinea pig, horse, human, mouse, porcine, rabbit, rat, sheep |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against IL13RA1. It was validated on Western BlotTarget Description: The protein encoded by this gene is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with IL4 receptor alpha, a subunit shared by IL13 and IL4 receptors. This subunit serves as a primary IL13-binding subunit of the IL13 receptor, and may also be a component of IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the N-terminal region of IL13RA1 |
| Other Names | [interleukin-13 receptor subunit alpha-1; Interleukin-13 receptor subunit alpha-1; interleukin-13 receptor subunit alpha-1; interleukin 13 receptor subunit alpha 1; Cancer/testis antigen 19] |
| Gene, Accession # | [IL13RA1], Gene ID: 3597, NCBI: NP_001551, UniProt: P78552 |
| Catalog # | MBS3216013 |
| Price | $335 |
| Order / More Info | IL13RA1 - N-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies